7743.T
SEED Co.,Ltd. [7743.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
7743.T Stock Summary
Top 10 Correlated ETFs
7743.T
Top 10 Correlated Stocks
7743.T
In the News
7743.T Financial details
Company Rating
Strong Buy
Market Cap
18.37B
Income
648.96M
Revenue
32.05B
Book val./share
514.91
Cash/share
242.9
Dividend
12
Dividend %
1.42%
Employees
974
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
56.12
Forward P/E
-
PEG
-12.83
P/S
0.67
P/B
1.69
P/C
2.37
P/FCF
-
Quick Ratio
0.58
Current Ratio
0.97
Debt / Equity
1.76
LT Debt / Equity
0.63
-
-
EPS (TTM)
25.93
EPS next Y
-
EPS next Q
-
EPS this Y
-127.4%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
0.74%
Revenue Q/Q
2.34%
EPS Q/Q
1.81%
-
-
-
-
SMA20
-9.49%
SMA50
-23.73%
SMA100
-22.75%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
3%
ROC
0.06%
Gross Margin
41%
Oper. Margin
5%
Profit Margin
1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
540.0-892.0
52W High
-35.54%
52W Low
+6.48%
RSI
24
Rel Volume
1.17
Avg Volume
96.09K
Volume
112K
Perf Week
-6.81%
Perf Month
-14.18%
Perf Quarter
-23.33%
Perf Half Y
-27.58%
-
-
-
-
Beta
0.306
-
-
Volatility
12.2%, 29.26%
Prev Close
-2.04%
Price
575
Change
-2.04%
7743.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.18K | 1.27K | 1.14K | 1.15K | 1.22K | |
| Net income per share | 38.5 | 10.1 | 45.13 | 46.09 | -12.63 | |
| Operating cash flow per share | -6.8 | 155.68 | 147.41 | 130.48 | 133.68 | |
| Free cash flow per share | -67.25 | 51.66 | 60.53 | 85.86 | 111.33 | |
| Cash per share | 105.53 | 136.27 | 150.66 | 141.61 | 185.16 | |
| Book value per share | 429.68 | 424.43 | 459.07 | 489.63 | 473.83 | |
| Tangible book value per share | 373.19 | 363 | 423.79 | 425.94 | 437.13 | |
| Share holders equity per share | 429.68 | 424.43 | 459.07 | 489.63 | 473.83 | |
| Interest debt per share | 890.53 | 941.51 | 922.63 | 889.49 | 844.95 | |
| Market cap | 28.86B | 20.38B | 19.78B | 13.04B | 13.67B | |
| Enterprise value | 48.38B | 40.14B | 38.75B | 31.26B | 29.7B | |
| P/E ratio | 29.94 | 80.56 | 17.51 | 11.3 | -43.24 | |
| Price to sales ratio | 0.98 | 0.64 | 0.69 | 0.45 | 0.45 | |
| POCF ratio | -169.48 | 5.23 | 5.36 | 3.99 | 4.08 | |
| PFCF ratio | -17.15 | 15.76 | 13.05 | 6.07 | 4.9 | |
| P/B Ratio | 2.68 | 1.92 | 1.72 | 1.06 | 1.15 | |
| PTB ratio | 2.68 | 1.92 | 1.72 | 1.06 | 1.15 | |
| EV to sales | 1.64 | 1.26 | 1.35 | 1.08 | 0.97 | |
| Enterprise value over EBITDA | 10.96 | 8.82 | 9.19 | 7.57 | 8.64 | |
| EV to operating cash flow | -284.07 | 10.3 | 10.5 | 9.57 | 8.88 | |
| EV to free cash flow | -28.74 | 31.04 | 25.57 | 14.54 | 10.66 | |
| Earnings yield | 0.03 | 0.01 | 0.06 | 0.09 | -0.02 | |
| Free cash flow yield | -0.06 | 0.06 | 0.08 | 0.16 | 0.2 | |
| Debt to equity | 2.06 | 2.2 | 2 | 1.8 | 1.77 | |
| Debt to assets | 0.55 | 0.56 | 0.56 | 0.53 | 0.52 | |
| Net debt to EBITDA | 4.42 | 4.34 | 4.5 | 4.41 | 4.66 | |
| Current ratio | 0.94 | 0.86 | 1.01 | 1.06 | 1.02 | |
| Interest coverage | 12.66 | 10.72 | 7.06 | 6.83 | 3.5 | |
| Income quality | -0.11 | 7.94 | 2.4 | 2.26 | -57.73 | |
| Dividend Yield | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Payout ratio | 0.24 | 1.19 | 0.27 | 0.26 | -0.95 | |
| Sales general and administrative to revenue | 0.32 | 0.33 | 0.33 | 0.33 | 0.33 | |
| Research and developement to revenue | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.03 | 0.04 | 0.03 | |
| Capex to operating cash flow | 8.89 | -0.67 | -0.59 | -0.34 | -0.17 | |
| Capex to revenue | -0.05 | -0.08 | -0.08 | -0.04 | -0.02 | |
| Capex to depreciation | -0.62 | -0.94 | -0.77 | -0.39 | -0.21 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 610.12 | 310.64 | 682.72 | 712.6 | 366.9 | |
| ROIC | 0.03 | 0.02 | 0.02 | 0.03 | 0.11 | |
| Return on tangible assets | 0.03 | 0.01 | 0.03 | 0.03 | -0.01 | |
| Graham Net | -719.23 | -767.78 | -720.65 | -707.67 | -629.67 | |
| Working capital | -1.16B | -2.81B | 201.65M | 922.4M | 295.27M | |
| Tangible asset value | 9.34B | 9.09B | 10.61B | 10.66B | 10.94B | |
| Net current asset value | -12.04B | -13.34B | -12.5B | -11.92B | -10.25B | |
| Invested capital | 2.06 | 2.2 | 2 | 1.8 | 1.77 | |
| Average receivables | 6.72B | 6.34B | 5.74B | 5.6B | 5.41B | |
| Average payables | 850.11M | 775.82M | 637.1M | 567.21M | 637.25M | |
| Average inventory | 5.56B | 7.2B | 7.38B | 7.38B | 7.35B | |
| Days sales outstanding | 84.07 | 67.7 | 71.21 | 71.21 | 61.97 | |
| Days payables outstanding | 18.68 | 15.06 | 12.34 | 12.73 | 13.23 | |
| Days of inventory on hand | 155.28 | 156.28 | 162.5 | 163.75 | 137.46 | |
| Receivables turnover | 4.34 | 5.39 | 5.13 | 5.13 | 5.89 | |
| Payables turnover | 19.54 | 24.24 | 29.59 | 28.68 | 27.58 | |
| Inventory turnover | 2.35 | 2.34 | 2.25 | 2.23 | 2.66 | |
| ROE | 0.09 | 0.02 | 0.1 | 0.09 | -0.03 | |
| Capex per share | -60.45 | -104.03 | -86.88 | -44.61 | -22.35 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 311.2 | 316.33 | 317.69 | 319.35 | 326.83 | |
| Net income per share | 5.41 | -23.37 | 17.03 | 15.99 | 16.28 | |
| Operating cash flow per share | 53.33 | 56.39 | 50.24 | 53.25 | 58.95 | |
| Free cash flow per share | 53.33 | 56.39 | 50.24 | 53.25 | 58.95 | |
| Cash per share | 179.59 | 182.4 | 160.11 | 229.65 | 242.9 | |
| Book value per share | 493.66 | 473.83 | 478.91 | 499.33 | 514.91 | |
| Tangible book value per share | 438 | 437.13 | 443.78 | 464.61 | 482.08 | |
| Share holders equity per share | 493.66 | 473.83 | 478.91 | 499.33 | 514.91 | |
| Interest debt per share | 857.34 | 839.65 | 875.24 | 892.62 | 908.75 | |
| Market cap | 12.62B | 13.67B | 14.62B | 20.8B | 20.45B | |
| Enterprise value | 29.54B | 29.7B | 31.31B | 37.39B | 37.06B | |
| P/E ratio | 23.27 | -5.84 | 8.57 | 13 | 12.55 | |
| Price to sales ratio | 1.62 | 1.73 | 1.84 | 2.6 | 2.5 | |
| POCF ratio | 9.45 | 9.68 | 11.63 | 15.61 | 13.86 | |
| PFCF ratio | 9.45 | 9.68 | 11.63 | 15.61 | 13.86 | |
| P/B Ratio | 1.02 | 1.15 | 1.22 | 1.66 | 1.59 | |
| PTB ratio | 1.02 | 1.15 | 1.22 | 1.66 | 1.59 | |
| EV to sales | 3.79 | 3.75 | 3.94 | 4.68 | 4.53 | |
| Enterprise value over EBITDA | 97.73 | -148.41 | 41.42 | 53.52 | 75.52 | |
| EV to operating cash flow | 22.13 | 21.04 | 24.9 | 28.05 | 25.12 | |
| EV to free cash flow | 22.13 | 21.04 | 24.9 | 28.05 | 25.12 | |
| Earnings yield | 0.01 | -0.04 | 0.03 | 0.02 | 0.02 | |
| Free cash flow yield | 0.11 | 0.1 | 0.09 | 0.06 | 0.07 | |
| Debt to equity | 1.73 | 1.77 | 1.82 | 1.78 | 1.76 | |
| Debt to assets | 0.52 | 0.52 | 0.53 | 0.52 | 0.52 | |
| Net debt to EBITDA | 55.98 | -80.11 | 22.08 | 23.74 | 33.84 | |
| Current ratio | 1.03 | 1.02 | 0.96 | 0.97 | 0.98 | |
| Interest coverage | 7.29 | -3.79 | 13.9 | 13.3 | 8.74 | |
| Income quality | 9.82 | -2.41 | 2.95 | 3.33 | 3.62 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0.21 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.06 | 0.07 | 0.07 | 0.06 | 0.07 | |
| Intangibles to total assets | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 245.24 | 499.19 | 428.39 | 423.8 | 434.3 | |
| ROIC | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| Return on tangible assets | 0 | -0.02 | 0.01 | 0.01 | 0.01 | |
| Graham Net | -641.31 | -632.44 | -701.87 | -680.01 | -685.6 | |
| Working capital | 578.94M | 295.27M | -665.44M | -515.27M | -377.95M | |
| Tangible asset value | 10.96B | 10.94B | 11.11B | 11.63B | 12.07B | |
| Net current asset value | -10.14B | -10.25B | -11.2B | -11.71B | -12B | |
| Invested capital | 1.73 | 1.77 | 1.82 | 1.78 | 1.76 | |
| Average receivables | 5.09B | 5.15B | 5.25B | 5.25B | 5.12B | |
| Average payables | 661.02M | 642.49M | 603.74M | 472.42M | 451.32M | |
| Average inventory | 8.38B | 7.68B | 7.01B | 6.91B | 6.93B | |
| Days sales outstanding | 58.92 | 59.03 | 59.95 | 58.61 | 55.34 | |
| Days payables outstanding | 11.22 | 12.26 | 10.44 | 8.83 | 9.45 | |
| Days of inventory on hand | 154.17 | 127.35 | 138.08 | 144.3 | 136.81 | |
| Receivables turnover | 1.53 | 1.52 | 1.5 | 1.54 | 1.63 | |
| Payables turnover | 8.02 | 7.34 | 8.62 | 10.19 | 9.52 | |
| Inventory turnover | 0.58 | 0.71 | 0.65 | 0.62 | 0.66 | |
| ROE | 0.01 | -0.05 | 0.04 | 0.03 | 0.03 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
7743.T Frequently Asked Questions
What is SEED Co.,Ltd. stock symbol ?
SEED Co.,Ltd. is a JP stock and trading under the symbol 7743.T
What is SEED Co.,Ltd. stock quote today ?
SEED Co.,Ltd. stock price is $575 today.
Is SEED Co.,Ltd. stock public?
Yes, SEED Co.,Ltd. is a publicly traded company.
Company Profile
- Volume Average 96.09K
- Market Capitalization 18.37B
- Employee 974
- CEO Mr. Masahiro Urakabe
- Headquarters Tokyo,JP
- IPO Date 2000-01-04
-
Website
https://www.seed.co.jp 
SEED Co.,Ltd. manufactures and supplies contact lenses, care products, spectacle frames, and other eye care products in Japan and internationally. The company offers SEED 1dayPure moisture daily disposable, SEED 1dayPure moisture multistage, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV contact lenses, as well as SEED 1dayPure moisture contact lenses for astigmatism. It also provides SEED 2weekPure moisture disposable contact lenses and SEED 2weekPure moisture multistage bifocal lenses, as well as SEED 2weekPure moisture contact lenses for astigmatism; SEED MonthlyFine UV and monthly color lens UV replacement contact lenses; rigid gas permeable contact lenses; and medical contact lenses. In addition, the company offers glass frames under the Vivid Moon, ViVi fleurs, and Plusmix brand names; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products for better vision. SEED Co., Ltd. was founded in 1957 and is headquartered in Tokyo, Japan.
